Century Therapeutics Inc (IPSC) — Long-term Investment Intensity
Century Therapeutics Inc (IPSC) has a Long-term Investment Intensity of 0.9% as of June 2025. Long-term investments of $2.69 Million represent 0.9% of total assets of $284.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Century Therapeutics Inc (IPSC) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Century Therapeutics Inc Long-term Investment Intensity (2019–2024)
This chart shows how Century Therapeutics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the intensity stands at 0.9%, reflecting long-term investments of $2.69 Million against total assets of $284.69 Million USD. Explore IPSC operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Century Therapeutics Inc (2019–2024)
The table below presents the year-by-year Long-term Investment Intensity for Century Therapeutics Inc from 2019 to 2024, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Century Therapeutics Inc stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 8.7% | $30.82 Million | $353.22 Million | ▼ -16.0 pp |
| 2023 | 24.7% | $89.10 Million | $360.69 Million | ▲ +14.0 pp |
| 2022 | 10.7% | $51.85 Million | $486.54 Million | ▼ -20.4 pp |
| 2021 | 31.1% | $135.91 Million | $437.38 Million | ▲ +30.1 pp |
| 2020 | 1.0% | $1.05 Million | $106.78 Million | ▼ -3.5 pp |
| 2019 | 4.5% | $4.08 Million | $90.90 Million | — |